These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25633468)

  • 41. Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow-up study.
    Paoluzi OA; Iacopini F; Pica R; Crispino P; Marcheggiano A; Consolazio A; Rivera M; Paoluzi P
    Aliment Pharmacol Ther; 2005 May; 21(9):1111-9. PubMed ID: 15854173
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-dose mesalazine treatment for ulcerative colitis patients who relapse under low-dose maintenance therapy.
    Yamamoto T; Umegae S; Matsumoto K
    Dig Liver Dis; 2011 May; 43(5):386-90. PubMed ID: 21195041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials.
    Lichtenstein GR; Zakko S; Gordon GL; Murthy U; Sedghi S; Pruitt R; Merchant K; Bortey E; Forbes WP
    Aliment Pharmacol Ther; 2012 Jul; 36(2):126-34. PubMed ID: 22617015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis.
    Eliakim R; Tulassay Z; Kupcinskas L; Adamonis K; Pokrotnieks J; Bar-Meir S; Lavy A; Mueller R; Greinwald R; Chermesh I; Gross V;
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1237-49. PubMed ID: 17944738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.
    Biancone L; Gionchetti P; Blanco Gdel V; Orlando A; Annese V; Papi C; Sostegni R; D'Incà R; Petruzziello C; Casa A; Sica G; Calabrese E; Campieri M; Pallone F
    Dig Liver Dis; 2007 Apr; 39(4):329-37. PubMed ID: 17347061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A case of inferior vena cava thrombosis and acute pancreatitis in a patient with ulcerative colitis].
    Shin DH; Lee KH; Kim CH; Kim KH; Park SH; Chang DK; Lee JK; Lee KT
    Korean J Gastroenterol; 2010 Oct; 56(4):255-9. PubMed ID: 20962562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lung disease and ulcerative colitis--mesalazine-induced bronchiolitis obliterans with organizing pneumonia or pulmonary manifestation of inflammatory bowel disease?
    Moeser A; Pletz MW; Hagel S; Kroegel C; Stallmach A
    Z Gastroenterol; 2015 Sep; 53(9):1091-8. PubMed ID: 26367026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Eosinophilic pneumonia caused by mesalazine. Report of one case].
    Pérez C; Errázuriz I; Brockmann P; González S; Cofré C
    Rev Med Chil; 2003 Jan; 131(1):81-4. PubMed ID: 12643224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Double-blind comparative study of sulfasalazine and controlled-release mesalazine tablets in the treatment of active ulcerative colitis.
    Munakata A; Yoshida Y; Muto T; Tsuchiya S; Fukushima T; Hiwatashi N; Kobayashi K; Kitano A; Shimoyama T; Inoue M
    J Gastroenterol; 1995 Nov; 30 Suppl 8():108-11. PubMed ID: 8563868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A case of mesalazine-induced pleuritis with hemophagocytic findings].
    Yamauchi K; Takeda H; Kobayashi K; Watanabe K; Machida Y; Suzuki H
    Nihon Kokyuki Gakkai Zasshi; 2005 Sep; 43(9):518-22. PubMed ID: 16218420
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mesalazine-induced eosinophilic pneumonia.
    Tanigawa K; Sugiyama K; Matsuyama H; Nakao H; Kohno K; Komuro Y; Iwanaga Y; Eguchi K; Kitaichi M; Takagi H
    Respiration; 1999; 66(1):69-72. PubMed ID: 9973695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A case of lung injury induced by long-term administration of mesalazine].
    Shindoh Y; Horaguchi R; Hayashi K; Suda Y; Iijima H; Shindoh C
    Nihon Kokyuki Gakkai Zasshi; 2011 Nov; 49(11):861-6. PubMed ID: 22171492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis - a pooled analysis.
    Leifeld L; Pfützer R; Morgenstern J; Gibson PR; Marakhouski Y; Greinwald R; Mueller R; Kruis W
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1115-22. PubMed ID: 21923715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 5-Aminosalicylate intolerance causing exacerbation in pediatric ulcerative colitis.
    Shimizu H; Arai K; Tang J; Hosoi K; Funayama R
    Pediatr Int; 2017 May; 59(5):583-587. PubMed ID: 28063246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of pharmacoepidemiology studies in addressing pharmacovigilance questions: a case example of pancreatitis risk among ulcerative colitis patients using mesalazine.
    Russo L; Schneider G; Gardiner MH; Lanes S; Streck P; Rosen S
    Eur J Clin Pharmacol; 2014 Jun; 70(6):709-17. PubMed ID: 24609467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.
    Hanauer SB
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():37-40. PubMed ID: 16961743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Interstitial pneumonia related to mesalamine].
    Lamsiah T; Moudden K; Baaj M; Hadri L
    Gastroenterol Clin Biol; 2010 Mar; 34(3):224-6. PubMed ID: 20299168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mesalazine-probiotics beads for acetic acid experimental colitis: formulation and characterization of a promising new therapeutic strategy for ulcerative colitis.
    Vishwakarma N; Ganeshpurkar A; Pandey V; Dubey N; Bansal D
    Drug Deliv; 2015 Jan; 22(1):94-9. PubMed ID: 24491122
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Rescue therapy with sulfasalazine prior to immunosuppressive or biological agents in ulcerative colitis poorly controlled with mesalazine].
    Martínez González J; Busto Bea V; Mesonero Gismero F; Parejo Carbonell S; Garrido E; López San Román A
    Gastroenterol Hepatol; 2013 Jan; 36(1):7-10. PubMed ID: 23195755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug-induced pulmonary toxicity in a patient treated with mesalazine and azathioprine for ulcerative colitis.
    Katsenos S; Psathakis K; Kokkonouzis I; Panagou P; Tsintiris K; Bouros D
    Acta Gastroenterol Belg; 2007; 70(3):290-2. PubMed ID: 18074739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.